Our Mission

Bridging Innovation and Opportunity

Biobook uses big data and AI matching technology to bridge information gaps between early-stage Korean life science ventures and global pharmaceutical companies and investors.

Contact
About Biobook

Turning Vision into Value, Together

With digital transformation and AI, we connect innovators with the right investors and partners to maximize the chance that early-stage healthcare innovation becomes a successful business.

2,250+

Korean life science startups

1,030+

Global life science VCs

1,540+

Global mid-sized pharmaceutical companies

45+

Global network countries

Our History

Our Journey of Innovation

  1. 2020.12

    Founded

  2. 2021.08

    Certified venture company

  3. 2021.12

    Seed investment

  4. 2022.05

    Pre-Series A investment

  5. 2022.08

    Scoring service patent filed

  6. 2023.06

    Chungbuk CCEI partner organization

  7. 2023.08

    Selected for R&D TIPS and TIPS Global Marketing

  8. 2023.10

    Global partnering service launched

  9. 2024.08

    Biobook Platform MVP version launched

  10. 2025.08

    Accelerator license acquired

  11. 2026.01

    Registered provider for export/innovation voucher bio consulting

  12. 2026.08

    Biobook officially launched

Our Services

Smart Growth, Global Connection

Super Connector

Smart Search & Matching

Use AI-powered search to identify domestic and global partners aligned with your technology and business needs, then connect through inquiries and meetings.

Classification Search

Explore Korean life science companies by indication, modality, technology area, and other industry classifications.

Cluster Search

Search companies by regional and institutional clusters to identify relevant collaboration opportunities.

Global Partnering Insights

Access intelligence on the priority indications and modalities of global pharmaceutical companies and investors, including technology-sourcing, investment, and broader partnering strategies.

Financial Advisory

Out-Licensing Strategy

Define out-licensing positioning, objectives, and an execution strategy based on the asset's differentiation and market potential.

Fundraising Advisory

Shape the fundraising strategy, tailored IR materials, and key metrics needed for effective investor communication.

Partner Discovery

Identify global pharma and investor prospects for technology transfer, co-development, and fundraising.

Deal Execution

Support the full transaction process, including due diligence, transaction term negotiations, and contract execution.

IR Support

Commercialization Strategy

Support both basic content production and the development of strategic materials focused on concrete commercialization goals.

IR Content Production

Produce a wide range of investor-relations content, from IR decks to video-based materials, that effectively communicates the strengths of each company and its technology.

IR Content Distribution

Distribute IR content through the Biobook platform and diverse online and offline channels in Korea and abroad to expand partnering and investment opportunities.

Open Innovation

Identify the needs of domestic and international pharmaceutical companies and investors, then connect them with promising companies to create new opportunities for innovation.

Get Started

We help with fundraising, opportunity discovery, and business growth.

Contact